Solitary pulmonary nodule
Solitary pulmonary nodule
Causes, incidence, and risk factors
More than half of all solitary pulmonary nodules are noncancerous (benign). Benign nodules have many causes, including old scars and infections.
Infectious granulomas (reactions to a past infection) cause most benign lesions. Common infections that increase the risk for developing a solitary pulmonary nodule include:
- Tuberculosis or having been exposed to TB
- Lung diseases caused by a fungus, such as:
Lung cancer is the most common cause of cancerous (malignant) pulmonary nodules.
The nodule itself rarely causes symptoms.
Signs and tests
A solitary pulmonary nodule is most often found on a chest x-ray or a chest CT scan, which are often done for other symptoms or reasons.
Your doctor must decide whether the nodule in your lung is probably benign (not cancer). This is more likely if:
- The nodule is small, has a smooth border, and has a solid and even appearance on an x-ray or CT scan
- You are young and do not smoke
Your doctor may then choose to just watch the nodule on x-rays.
- Repeat chest x-rays or chest CT scans are the most common way to follow the nodule. Rarely, lung PET scans may be done.
- If repeated x-rays show that the nodule size has not changed in 2 years, it is most likely benign and a biopsy is not needed.
Your doctor may choose to biopsy the nodule to rule out cancer if:
- You are a smoker
- You have other symptoms of lung cancer
- The nodule has grown in size or has changed compared to earlier x-rays
Skin tests to rule out tuberculosis and other infections may also be done.
Ask your doctor about the risks of having a biopsy versus monitoring the size of the nodule with regular x-rays or CT scans. Treatment may be based on the results of the biopsy or other tests.
The outlook is usually good if the nodule is benign. If the nodule does not grow larger over a 2-year period, often nothing more needs to be done.
Gould MK, Fletcher J, Iannettoni MD, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:108S-130S.
Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:94S-107S.
Albert RH, Russell JJ. Evaluation of the solitary pulmonary nodule. Am Fam Physician. 2009;80:827-831.
Ettinger DS. Lung cancer and other pulmonary neoplasms. In: Goldman L, Ausiello D, eds. Cecil Medicine. 24th ed. Philadelphia, Pa: Saunders Elsevier; 2011:chap 197.
Reviewed by:Linda J. Vorvick, MD, Medical Director, MEDEX Northwest Division of Physician Assistant Studies, University of Washington, School of Medicine; and Yi-Bin Chen, MD, Leukemia/Bone Marrow Transplant Program, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorousstandards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information andservices. Learn more about A.D.A.M.'s editorialpolicy, editorialprocess, and privacypolicy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch.)
The information provided herein should not be used during any medical emergency or for the diagnosis or treatmentof any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions.Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 2015 A.D.A.M., Inc. Any duplication ordistribution of the information contained herein is strictly prohibited.